Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Both Semaglutide and Tirzepatide are medications that have shown significant effectiveness in promoting consistent and sustainable weight loss through appetite suppression, regulation of blood sugar, enhanced calorie expenditure, body fat reduction, and satiety for greater portion control
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
Efficacy and safety of oral small molecule glucagon-like peptide 1 receptor agonist danuglipron for glycemic control among patients with type 2 diabetes: A randomized clinical trial
Watch this video to learn more
Polycystic ovary syndrome | Treatment summaries | BNF
The prescription is part of that care
